Literature DB >> 8402050

Surgical reintervention for differentiated thyroid cancer.

P E Goretzki1, D Simon, A Frilling, J Witte, C Reiners, M Grussendorf, F A Horster, H D Röher.   

Abstract

Reoperation was performed in 110 of 185 patients with a differentiated thyroid carcinoma. In 25 patients (23 per cent) the indication for reintervention was a large thyroid remnant and in the other 85 (77 per cent) persistent or recurrent cancer was suspected. In 32 (29 per cent) of the 110 patients undergoing reoperation no evidence of cancer tissue was found. Tumour tissue in 33 patients (30 per cent) was resectable. Of 45 patients (41 per cent) with residual tumour after operation 24 showed only occult thyroid carcinoma with a raised serum thyroglobulin level. Eight of 21 patients with macroscopically persistent tumour died from the disease during a mean follow-up of 2.3 years. In 13 of 38 patients the investigated recurrent tumours were histologically less differentiated than the primary lesions, stressing the importance of total tumour clearance. The treatment of choice for persistent and recurrent differentiated thyroid carcinoma is surgical reintervention, if feasible, before radioiodine and radiation therapy are considered.

Entities:  

Mesh:

Year:  1993        PMID: 8402050     DOI: 10.1002/bjs.1800800826

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  21 in total

1.  A phase II trial of valproic acid in patients with advanced, radioiodine-resistant thyroid cancers of follicular cell origin.

Authors:  Naris Nilubol; Roxanne Merkel; Lily Yang; Dhaval Patel; James C Reynolds; Samira M Sadowski; Vladimir Neychev; Electron Kebebew
Journal:  Clin Endocrinol (Oxf)       Date:  2016-09-08       Impact factor: 3.478

2.  On-site ultrasound-guided localization for impalpable nodal recurrences in papillary thyroid carcinoma patients.

Authors:  Kuk-Jin Kim; Bup-Woo Kim; Yong Sang Lee; Hang-Seok Chang; Cheong Soo Park
Journal:  J Korean Surg Soc       Date:  2013-08-26

3.  Preoperative neck ultrasonographic mapping for persistent/recurrent papillary thyroid cancer.

Authors:  Hussam M Binyousef; Ali S Alzahrani; Saif S Al-Sobhi; Suhaibani Hamed S Al; Mohammed A Chaudhari; Hussain M Raef
Journal:  World J Surg       Date:  2004-11       Impact factor: 3.352

4.  Radioguided occult lesion localization in patients with recurrent thyroid cancer.

Authors:  Murat Tuncel; Nilda Süslü
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-03-18       Impact factor: 2.503

5.  Fungating thyroid cancer: a complex clinical scenario.

Authors:  A S Nabawi; H F Al Wagih; M A Hemeida; T Y Koraitim; M Moussa; Tarek Ezzat
Journal:  World J Surg       Date:  2012-03       Impact factor: 3.352

Review 6.  Morbidity of central neck dissection for papillary thyroid cancer.

Authors:  Davide Lombardi; Remo Accorona; Alberto Paderno; Carlo Cappelli; Piero Nicolai
Journal:  Gland Surg       Date:  2017-10

Review 7.  [Reoperation for thyroid cancer].

Authors:  H Vogelsang; T Brückner; K Scheidhauer; M Schwaiger; J R Siewert
Journal:  Chirurg       Date:  2005-03       Impact factor: 0.955

8.  [Need for thyroidectomy in differentiated thyroid cancers].

Authors:  S Samel; C Käufer
Journal:  Langenbecks Arch Chir       Date:  1995

Review 9.  Radio-guided surgery for persistent differentiated papillary thyroid cancer: case presentations and review of the literature.

Authors:  T Negele; G Meisetschläger; T Brückner; K Scheidhauer; M Schwaiger; H Vogelsang
Journal:  Langenbecks Arch Surg       Date:  2006-02-21       Impact factor: 3.445

10.  A regional study of thyroidectomy: surgical pathology suggests scope to improve quality and reduce cost.

Authors:  G Asimakopoulos; T Loosemore; R C Bowyer; G McKee; A E Giddings
Journal:  Ann R Coll Surg Engl       Date:  1995-11       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.